4.2 Article

SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells

期刊

RETROVIROLOGY
卷 9, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1742-4690-9-87

关键词

SAMHD1; Quiescent CD4(+) T-cell; HIV-1; Reverse transcription; Restriction

类别

资金

  1. ERC [250333]
  2. Sidaction (fonds de dotation Pierre Berge)
  3. ANRS
  4. FRM equipe labellisee
  5. SIDACTION
  6. MESR
  7. Ecole de l'INSERM-Liliane Bettencourt
  8. FRM
  9. Areva
  10. Labex IBEID program
  11. Vaccine Research Institute
  12. European Research Council (ERC) [250333] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

Background: Quiescent CD4(+) T lymphocytes are highly refractory to HIV-1 infection due to a block at reverse transcription. Results: Examination of SAMHD1 expression in peripheral blood lymphocytes shows that SAMHD1 is expressed in both CD4+ and CD8+ T cells at levels comparable to those found in myeloid cells. Treatment of CD4+ T cells with Virus-Like Particles (VLP) containing Vpx results in the loss of SAMHD1 expression that correlates with an increased permissiveness to HIV-1 infection and accumulation of reverse transcribed viral DNA without promoting transcription from the viral LTR. Importantly, CD4(+) T-cells from patients with Aicardi-Goutieres Syndrome harboring mutation in the SAMHD1 gene display an increased susceptibility to HIV-1 infection that is not further enhanced by VLP-Vpx-treatment. Conclusion: Here, we identified SAMHD1 as the restriction factor preventing efficient viral DNA synthesis in non-cycling resting CD4(+) T-cells. These results highlight the crucial role of SAMHD1 in mediating restriction of HIV-1 infection in quiescent CD4(+) T-cells and could impact our understanding of HIV-1 mediated CD4(+) T-cell depletion and establishment of the viral reservoir, two of the HIV/AIDS hallmarks.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据